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Abstract
Background: This study was undertaken to determine the optimal cut-off value for FSH to predict the presence of
spermatogenesis in patients with non-obstructive azoospermia.
Methods: A total of 206 non-obstructive azoospermic men were enrolled in this prospective study. By using
receiver operating characteristic (ROC) curves, we determined the optimal cut-off value for FSH and evaluated
whether the test could adequately predict successful sperm retrieval.
Results: There were 108 non-obstructive azoospermic patients who had evidence of spermatogenesis (group A)
and achieved success in sperm retrieval. Another 98 non-obstructive azoospermic patients (group B) failed in
sperm retrieval. The mean value of serum FSH in group B was significantly higher than in group A (28.03 +/- 14.56
mIU/mL vs 7.94 +/- 4.95 mIU/mL, p < 0.01; respectively). The area under the receiver operating characteristic curves
were 0.939 +/- 0.02 and a cut-off value of 19.4 mIU/mL discriminated between group A and B with a sensitivity of
70%. The positive predictive value for failed sperm retrieval (group B) can reach 100%.
Conclusions: Elevated plasma levels of FSH of more than 19.4 mIU/mL could be used as a reliable criterion for a
trial of sperm retrieval from testes in artificial reproductive techniques.
Background
A normal hypothalamic-pituitary-gonadal axis is usually
a necessary prerequisite for spermatogenesis[1]. Hormo-
nal control of the hypothalamic-pituitary-gonadal axis
involves a negative feedback mechanism[2,3]. The gona-
dotropin-releasing hormone (GnRH) is secreted from
the hypothalamus and stimulates the production of folli-
cle-stimulating hormone (FSH) and luteinizing hormone
(LH) from the basophilic cells in the anterior lobe of the
pituitary gland[4]. The primary site of FSH action is on
the Sertoli cells of the seminiferous tubules to maintain
normal spermatogenesis. The Sertoli cells interact with
the spermatogenic cells and produce the inhibin B
which suppresses FSH secretion from the pituitary
gland. In the condition of spermatogenic failure, the
production of inhibin B is decreased and plasma FSH
increases[5].
Elevated FSH levels have been shown to be associated
with damage to the germinal epithelium of the semini-
ferous tubules[6]. Plasma FSH levels usually correlate
inversely with spermatogenesis, and therefore FSH is
considered to be a clinically useful endocrine marker in
the evaluation of infertile men. There is a consensus
that men with azoospermia and testicular atrophy with
significantly elevated FSH levels should undergo testicu-
lar biopsy if in vitro fertilization with intracytoplasmic
sperm injection (ICSI) is an acceptable approach for
both partners[7]. However, the diagnostic criterion of
elevated plasma FSH level is still controversial and con-
flicting recommendations with regard to FSH level have
been proposed [8,9]. Because an artificial reproductive
technique is an expensive procedure, we need an opti-
mal cut-off level for FSH to predict the success of
sperm retrieval for infertile couples. There is consider-
able overlap of increased FSH levels and completeness
of spermatogenesis so that even patients with Sertoli-
cell-only syndrome might have normal FSH levels and
conversely, patients with highly elevated FSH levels do
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not necessarily lose spermatogenesis. Although two to
three times the normal value has been recommended,
an optimal cut-off value in the differential diagnostic
evaluation of spermatogenic failure and obstructive
azoospermia has not yet been determined [8,9]. This
study was undertaken to determine the optimal cut-off
value for FSH to predict the presence of spermatogen-
esis in non-obstructive azoospermic patients.
Methods
Patients
From April 2003 to December 2006, a total of 206 non-
obstructive azoospermic men were enrolled in this pro-
spective study. The hospital ethical committee approved
the study protocol, and written informed consent was
obtained from each patient. These patients underwent a
complete examination to determine the etiology of
azoospermia, including a detailed history, physical exam-
ination, at least three consecutive semen analyses, chro-
mosomal karyotyping study and endocrinology profile
(FSH, LH, prolactin, and testosterone). All semen sam-
ples were obtained by masturbation after 3 days of sex-
ual abstinence and were evaluated on at least three
separate occasions, separated by a 3-week interval. After
liquefaction at room temperature, semen volume, pH,
sperm concentration, motility and morphology were
determined following WHO guidelines for semen analy-
sis[10]. Follicle-stimulating hormone was determined by
chemiluminescent immunometric assay using commer-
cial kits (IMMULITE 2000 FSH, Deerfield, IL USA). To
differentiate between obstructive and non-obstructive
azoospermia, a comprehensive diagnostic and therapeu-
tic procedure was carried out in one operative session
[11]. Briefly, wet prep analysis of testis tissue was per-
formed to detect the presence of sperm[12]. If sperma-
togenesis was noted, then vasography with saline
infusion was performed to make sure the vas deferens
was patent. Either sperm retrieval for freezing or micro-
scopic vasoepididymostomy can be performed. These
azoospermia cases were defined as successful sperm
retrieval (group A). If sperm were not found by both
wet prep examination and microscopic testicular sperm
extract, then ordinary testicular biopsy was performed.
At least three pieces of specimen for each testis will be
collected and these specimens were fixed in Bouin’s
solution for final histological diagnosis. These cases, in
which there were failure of sperm retrieval and histolo-
gical spermatogenic defects, such as Sertoli-cell-only,
maturation arrests, or severe fibrosis, were defined as
spermatogenic failure (group B).
Statistical analysis
All results are expressed as mean±standard deviation (S.
D.). The Student t test was used to compare serum FSH
levels between groups A and B. P values less than 0.05
were considered significant. Receiver operating charac-
teristic (ROC) curves were used to determine the opti-
mal cut-off value for FSH to assess whether the test
could adequately discriminate between groups A and B.
The ability of serum FSH to predict sperm retrieval was
estimated on the basis of sensitivity and specificity at
various cut-off values. An area under the ROC curve of
1.0 indicates perfect discrimination, whereas an area of
0.5 indicates that the test discriminates no better than
chance[13].
Results
The characteristics of the patients are presented in
Table 1. No significant difference was observed in mean
age between the two groups. There were 108 non-
obstructive azoospermic patients who had evidence of
spermatogenesis and success in sperm retrieval (group
A). The other 96 azoospermic patients had spermato-
genic failure (group B) and failed in sperm retrieval. The
histological findings in testicular biopsies were sperma-
togenic defects such as hypospermatogenesis, matura-
tion arrest, and Sertoli-cell-only syndrome. As shown in
Table 1, the mean value of serum FSH in group B
(28.03 ± 14.56 mIU/mL) was significantly higher than
that in group A (7.94 ± 4.95 mIU/mL, p < 0.01). In
order to confirm the ability of an elevated FSH level to
discriminate between these two groups we subjected our
results to receiver operating characteristic (ROC) curve
analysis.
Figure 1 depicts the ROC curves for FSH concentra-
tion. The area under the ROC curves was 0.939 ± 0.02
(with a 95% CI for the area being between 0.891 and
0.986). A cut-off value of 13.7 mIU/mL discriminated
between groups A and B with a sensitivity of 85.7% and
a specificity of 87.0%. When the cut-off value was
increased to 19.4 mIU/mL, the sensitivity was 85.7% and
the positive predictive value could reach 100%. As
shown in Figure 2, a cut-off value of 19.4 mIU/mL dis-
criminated between groups A and group B with a sensi-
tivity of 85.7% and a specificity of 100%. The positive







Mean ± SD 30.1 ± 4.2 29.8 ± 4.5 p = 0.69
Range 24-38 22-36
FSH (mIU/mL)
Mean ± SD 7.94 ± 4.95 28.03 ± 14.56 p < 0.01
Range 1.8-19.0 2.2-75.3
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predictive value for failed sperm retrieval (group B) can
reach 100%.
Discussion
The etiology of hypergonadotropism in azoospermic
patients has been well studied and is known to involve a
negative feedback mechanism involving Sertoli cells and
inhibin B[14]. Serum FSH can increase to as high as two
to four fold the normal range. Although FSH can facili-
tate the initiation of spermatogenesis in pubertal males,
hypogonadal men still can demonstrate fertility in the
absence of FSH. Only the combination of FSH and tes-
tosterone can support a qualitatively and quantitatively
full normal level of spermatogenesis.
In patients with obstructive azoospermia, if recon-
structive surgery fails or is not feasible, microscopic epi-
didymal sperm aspiration (MESA) or testicular sperm
extraction (TESE) is the method of choice for recovering
spermatozoa for in vitro fertilization (IVF). In patients
with non-obstructive azoospermia, TESE is the method
of choice for recovering spermatozoa as a male
therapeutic approach in ICSI. Due to the psychological,
economic, or physical burden of the IVF procedure, use-
ful criteria to predict the absence of spermatozoa are
highly important for making a decision of sperm retrie-
val procedure. Although histopathology has been found
to be the best method for predicting successful sperm
recovery in non-obstructive azoospermic patients, this
method requires an operative procedure[5,15]. Several
non-invasive laboratory tools have been suggested for
prediction of the presence of spermatozoa, such as the
levels of inhibin B and FSH in serum. Inhibin B level is
a parameter that has been shown to be associated with
maturation arrest; however, it is not used routinely and
is not diagnostic[16,17]. The combination of inhibin B
and FSH levels has been reported to be a better predic-
tor for the presence of sperm in TESE. However, the
prediction is not absolutely reliable[18]. FSH has been
used as a marker of spermatogenesis, but the optimal
criterion for serum level has still not been precisely
determined[5]. A two-fold increase above the upper
limit of normal serum FSH level has usually been used
as the cut-off value for spermatogenesis, but this does
not provide a better predictive rate than histopathology
[19]. It has been reported that when elevated plasma
levels of FSH are three fold above the normal limit
(more than 27 mIU/mL) this precludes, with a probabil-
ity of 95%, the existence of full spermatogenesis[20].
However, with regard to FSH plasma levels, a high FSH
level can not be used for the diagnosis of spermatogenic
maturation arrest and Sertoli-cell-only syndrome[20].
The predictive power for detecting oligospermia
among men with FSH above 10 IU/L has been found to
be 100%[5]. In a study of 106 azoospermic patients,
small testicular size (< 4 cm) and elevated FSH (> 10)
was associated with a decrease in the success rate of
sperm retrieval rate from 77% to 29%[21]. In another
report it was found that a level above 60 mIU/mL of
serum FSH could completely exclude the possibility of
sperm retrieval from testis; the sperm retrieval rate was
100% for FSH ≤15 mIU/mL [22]. Although measure-
ment of serum FSH is a non-invasive test for predicting
success rate of sperm retrieval in azoospermic patients,
the cut-off value for FSH for predicting spermatogenesis
is rather variable. We suggest that one major reason for
the variability is due to the development of microsurgi-
cal testicular sperm retrieval (microTESE). The micro-
TESE has better sperm retrieval rate than random
testicular biopsy. Many men who have been diagnosed
with non-obstructive azoospermia either due to the
pathological conditions known as hypospermatogenesis
or Sertoli-cell only syndrome have been found to have
foci of sperm production within the testicles. This
observation has revolutionized an old concept that the
testis produced sperm in a uniform fashion and has lead
Figure 1 Depiction of ROC curves of serum FSH can
discriminate between successful or failed sperm retrieval.
Depiction of receiver operating characteristic (ROC) curves of serum
follicle-stimulating hormone (FSH) can discriminate between
successful or failed sperm retrieval. The area under the ROC curves
was 0.939 ± 0.02 (with a 95% confidence interval for the area being
between 0.891 and 0.986). A FSH cut-off point of 13.7 mIU/mL
discriminated between groups A and B with a sensitivity of 85.7%
and a specificity of 87.0%. When the cut-off point was increased to
19.4 mIU/mL, the sensitivity of FSH level was 70% and the specificity
was 100%. Arrows indicate the cut-off point for serum FSH 19.4
mIU/mL.
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to the new concept of focal spermatogenesis. In our
study, we found that a low FSH level (< 19.4 mIU/mL)
is not a predictive criterion for success sperm retrieval.
A comprehensive diagnostic evaluation and reconstruc-
tive operative procedure are indicated for azoospermic
men with a low FSH level (< 19.4 mIU/mL). But men
with elevated FSH (> 19.4 mIU/mL) would benefit from
a cut-off value for FSH to predict the failure for sperm
retrieval. This is very important for microTESE, because
fresh testicular sperm will be needed to approve patients
for successful concomitant IVF and ICSI procedures.
Conclusions
Our data suggest that plasma FSH levels can be used to
predict the failure of sperm retrieval in patients with
azoospermia. Elevated plasma levels of FSH (> 19.4
mIU/mL) can preclude the presence of spermatogenesis
with a probability of 100%. When FSH was above the
level of 19.4 mIU/mL, there were no successful sperm
retrievals in our series. However, a normal value of FSH
does not predict normal spermatogenesis and successful
sperm retrieval. We suggest that a cut-off value of FSH
could be used as a reliable criterion for selecting
patients for a trial of sperm retrieval from testes using
an artificial reproductive technique.
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Figure 2 Dot diagram shows the serum FSH data and the cut-off point for sperm retrieval. Dot diagram shows the serum follicle-
stimulating hormone data and the cut-off point for sperm retrieval. The best cut-off point for failed sperm retrieval in non-obstructive
azoospermic patients is 19.4 mIU/mL. However, a value of FSH lower than 19.4 mIU/mL does not predict normal spermatogenesis and successful
sperm retrieval.
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